Long-term outcomes of children with intermediate sweat chloride values in infancy

Journal of Pediatrics

Volumn 166, Issue 6, 2015, Pages 1469-1474.e3

  Groves, Tyler ^a,b   Robinson, Paul ^a,b   Wiley, Veronica ^a,b   Fitzgerald, Dominic A ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHLORIDE; TRYPSINOGEN;

ARTICLE; BACTERIAL COLONIZATION; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE MUTATION; HUMAN; INFANCY; LONG TERM CARE; MALE; NEWBORN SCREENING; NUTRITION; OUTCOME ASSESSMENT; PANCREAS INSUFFICIENCY; PRIORITY JOURNAL; PROGNOSIS; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SPUTUM CULTURE; STAPHYLOCOCCUS AUREUS; SWEAT TEST; CHEMISTRY; INFANT; NEWBORN; PREDICTIVE VALUE; PRESCHOOL CHILD; PROCEDURES; SWEAT; TIME;

CHILD, PRESCHOOL; CHLORIDES; CYSTIC FIBROSIS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEONATAL SCREENING; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SWEAT; TIME FACTORS;

EID: 84930162784     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2015.01.052     Document Type: Article

References (27)

1. F.N. Dijk, and D.A. Fitzgerald The impact of newborn screening and earlier intervention on the clinical course of cystic fibrosis Paediatr Respir Rev 13 2012 220 225
2. P.M. Farrell, M.R. Kosorok, A. Laxova, G. Shen, R.E. Koscik, and W.T. Bruns Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group N Engl J Med 337 1997 963 969
3. P.M. Farrell, M.R. Kosorok, M.J. Rock, A. Laxova, L. Zeng, and H.C. Lai Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group Pediatrics 107 2001 1 13
4. R.L. Koscik, P.M. Farrell, M.R. Kosorok, K.M. Zaremba, A. Laxova, and H.C. Lai Cognitive function of children with cystic fibrosis: deleterious effect of early malnutrition Pediatrics 113 2004 1549 1558
5. F.N. Dijk, K. McKay, F. Barzi, K.J. Gaskin, and D.A. Fitzgerald Improved survival in cystic fibrosis patients diagnosed by newborn screening compared to a historical cohort from the same center Arch Dis Child 96 2011 1118 1123
6. S.M. Moskowitz, J.F. Chmiel, D.L. Sternen, E. Cheng, R.L. Gibson, and S.G. Marshall Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders Genet Med 10 2008 851 868
7. R.B. Parad, and A.M. Comeau Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm J Pediatr 147 2005 S78 S82
8. D. Borowitz, R.B. Parad, J.K. Sharp, K.A. Sabadosa, K.A. Robinson, and M.J. Rock Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond J Pediatr 155 2009 S106 S116
9. P.M. Farrell, B.J. Rosenstein, T.B. White, F.J. Accurso, C. Castellani, and G.R. Cutting Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report J Pediatr 153 2008 S4 S14
10. J. Massie, and B. Clements Diagnosis of cystic fibrosis after newborn screening: the Australasian experience - twenty years and five million babies later: a consensus statement from the Australasian Paediatric Respiratory Group Pediatr Pulmonol 39 2005 440 446
11. C.L. Ren, H. Desai, M. Platt, and M. Dixon Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome Pediatr Pulmonol 46 2011 1079 1084
12. D. Fitzgerald, P. Van Asperen, R. Henry, D. Waters, M. Freelander, and M. Wilson Delayed diagnosis of cystic fibrosis in children with a rare genotype (delta F508/R117H) J Paediatr Child Health 31 1995 168 171
13. B. Wilcken, V. Wiley, G. Sherry, and U. Bayliss Neonatal screening for cystic fibrosis: a comparison of two strategies for case detection in 1.2 million babies J Pediatr 127 1995 965 970
14. J.L. Bobadilla, M. Macek Jr., J.P. Fine, and P.M. Farrell Cystic fibrosis: a worldwide analysis of CFTR mutations - correlation with incidence data and application to screening Hum Mutat 19 2002 575 606
15. J.P. Clancy, S.M. Rowe, F.J. Accurso, M.L. Aitken, R.S. Amin, and M.A. Ashlock Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation Thorax 67 2012 12 18
16. L.E. Gibson, and R.E. Cooke A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis Pediatrics 23 1959 545 549
17. A.K. Evans, D.A. Fitzgerald, and K.O. McKay The impact of meconium ileus on the clinical course of children with cystic fibrosis Eur Respir J 18 2001 784 789
18. H. Shwachman, and L.L. Kulczycki Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period AMA J Dis Child 96 1958 6 15
19. S. Stanojevic, A. Wade, J. Stocks, J. Hankinson, A.L. Coates, and H. Pan Reference ranges for spirometry across all ages: a new approach Am J Respir Crit Care Med 177 2008 253 260
20. P. Desmarquest, D. Feldmann, A. Tamalat, M. Boule, B. Fauroux, and G. Tournier Genotype analysis and phenotypic manifestations of children with intermediate sweat chloride test results Chest 118 2000 1591 1597
21. I. Sermet-Gaudelus, E. Girodon, D. Sands, N. Stremmler, V. Vavrova, and E. Deneuville Clinical phenotype and genotype of children with borderline sweat test and abnormal nasal epithelial chloride transport Am J Respir Crit Care Med 182 2010 929 936
22. K.O. McKay, D.L. Waters, and K.J. Gaskin The influence of newborn screening for cystic fibrosis on pulmonary outcomes in New South Wales J Pediatr 147 2005 S47 S50
23. J.C. Davies Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence Paediatr Respir Rev 3 2002 128 134
24. A.M. de Vrankrijker, T.F. Wolfs, and C.K. van der Ent Challenging and emerging pathogens in cystic fibrosis Paediatr Respir Rev 11 2010 246 254
25. M.M. Treggiari, M. Rosenfeld, G. Retsch-Bogart, R. Gibson, and B. Ramsey Approach to eradication of initial Pseudomonas aeruginosa infection in children with cystic fibrosis Pediatr Pulmonol 42 2007 751 756
26. S.E. West, L. Zeng, B.L. Lee, M.R. Kosorok, A. Laxova, and M.J. Rock Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors JAMA 287 2002 2958 2967
27. J. Massie, L. Curnow, J. Glazner, D. Armstrong, and I. Francis Lessons learned from 20 years of newborn screening for cystic fibrosis Med J Aust 196 2012 67 70